vs

Side-by-side financial comparison of Commercial Bancgroup, Inc. (CBK) and SHOULDER INNOVATIONS, INC. (SI). Click either name above to swap in a different company.

Commercial Bancgroup, Inc. is the larger business by last-quarter revenue ($23.1M vs $11.8M, roughly 2.0× SHOULDER INNOVATIONS, INC.). Commercial Bancgroup, Inc. runs the higher net margin — 41.3% vs -74.3%, a 115.6% gap on every dollar of revenue.

Commercial Bancgroup, Inc. operates as a U.S. regional bank holding company that provides a full suite of retail and commercial banking products and services to individual consumers, small and medium-sized businesses, and local institutional clients. Its core offerings include deposit accounts, lending solutions, wealth management, and tailored financial advisory services for regional markets.

Shoulder Innovations, Inc. is a medical technology firm specializing in design, development, and commercialization of innovative orthopedic devices for shoulder replacement surgery. Its products reduce surgical complications, improve patient outcomes, and are sold to orthopedic surgeons and healthcare providers across North America and Western Europe.

CBK vs SI — Head-to-Head

Bigger by revenue
CBK
CBK
2.0× larger
CBK
$23.1M
$11.8M
SI
Higher net margin
CBK
CBK
115.6% more per $
CBK
41.3%
-74.3%
SI

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CBK
CBK
SI
SI
Revenue
$23.1M
$11.8M
Net Profit
$9.5M
$-8.7M
Gross Margin
76.2%
Operating Margin
-65.0%
Net Margin
41.3%
-74.3%
Revenue YoY
Net Profit YoY
9.7%
EPS (diluted)
$0.69
$-0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBK
CBK
SI
SI
Q1 26
$23.1M
Q4 25
$23.5M
Q3 25
$22.8M
$11.8M
Q2 25
$11.0M
Net Profit
CBK
CBK
SI
SI
Q1 26
$9.5M
Q4 25
$9.9M
Q3 25
$9.5M
$-8.7M
Q2 25
$-19.2M
Gross Margin
CBK
CBK
SI
SI
Q1 26
Q4 25
Q3 25
76.2%
Q2 25
76.2%
Operating Margin
CBK
CBK
SI
SI
Q1 26
Q4 25
Q3 25
53.8%
-65.0%
Q2 25
-53.2%
Net Margin
CBK
CBK
SI
SI
Q1 26
41.3%
Q4 25
42.2%
Q3 25
41.4%
-74.3%
Q2 25
-174.3%
EPS (diluted)
CBK
CBK
SI
SI
Q1 26
$0.69
Q4 25
$0.72
Q3 25
$0.77
$-0.64
Q2 25
$-165.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBK
CBK
SI
SI
Cash + ST InvestmentsLiquidity on hand
$54.9M
Total DebtLower is stronger
$118.2M
Stockholders' EquityBook value
$147.8M
Total Assets
$2.3B
$177.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBK
CBK
SI
SI
Q1 26
Q4 25
Q3 25
$154.8M
$54.9M
Q2 25
$27.1M
Total Debt
CBK
CBK
SI
SI
Q1 26
$118.2M
Q4 25
$166.8M
Q3 25
$100.1M
Q2 25
Stockholders' Equity
CBK
CBK
SI
SI
Q1 26
Q4 25
Q3 25
$245.2M
$147.8M
Q2 25
$-78.2M
Total Assets
CBK
CBK
SI
SI
Q1 26
$2.3B
Q4 25
$2.3B
Q3 25
$2.2B
$177.8M
Q2 25
$77.8M
Debt / Equity
CBK
CBK
SI
SI
Q1 26
Q4 25
Q3 25
0.41×
Q2 25

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBK
CBK
SI
SI
Operating Cash FlowLast quarter
$-8.6M
Free Cash FlowOCF − Capex
$-11.4M
FCF MarginFCF / Revenue
-96.7%
Capex IntensityCapex / Revenue
23.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBK
CBK
SI
SI
Q1 26
Q4 25
Q3 25
$28.0M
$-8.6M
Q2 25
$-11.3M
Free Cash Flow
CBK
CBK
SI
SI
Q1 26
Q4 25
Q3 25
$26.5M
$-11.4M
Q2 25
$-13.6M
FCF Margin
CBK
CBK
SI
SI
Q1 26
Q4 25
Q3 25
115.8%
-96.7%
Q2 25
-123.4%
Capex Intensity
CBK
CBK
SI
SI
Q1 26
Q4 25
Q3 25
6.7%
23.9%
Q2 25
21.0%
Cash Conversion
CBK
CBK
SI
SI
Q1 26
Q4 25
Q3 25
2.96×
Q2 25

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBK
CBK

Net Interest Income$20.5M89%
Noninterest Income$2.6M11%

SI
SI

Segment breakdown not available.

Related Comparisons